Osiris Reborn has never been able to escape the Mass Effect accusations. A space opera RPG, branching stories, real-time ...

Ocugen OCGN is pushing a modifier gene therapy platform across several retinal diseases where current options are limited, ...

Europe’s low and no-alcohol boom accelerates as innovators mimic alcohol warmth using piperine, niacin and dihydrochalcones ...

Genetics, right? Sort of. Scientists just learned it’s a bit more nuanced than high school biology.

In April 2026, Ocugen, Inc. reported full Phase 2 ArMaDa trial results for OCU410 in geographic atrophy secondary to dry age-related macular degeneration, showing a 46% reduction in macular lesion ...

After a total transmission failure on his 2021 Toyota Highlander XLE, owner Rob Kopty faces a dilemma: Is the warranty ...

Automakers called it lifetime fluid — your transmission paid the price.

There’s some debate over exactly when May 4 became known as “Star Wars Day.” Written records of the play on words “May the ...

In March 2026, the company's auditor expressed "substantial doubt" about Ocugen's ability to continue as a going concern. The balance sheet reveals total liabilities of approximately $55.7 million ...

Review: Offering two new character classes, a thrilling new campaign, and more, Lord of Hatred is an impressive expansion for ...